Home » Healthcare » U.S. Single-Use Bio-Processing Systems Market

U.S. Single-Use Bio-Processing Systems Market

U.S. Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Contract Manufacturing Organizations (CMOs), Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
U.S. Single-Use Bio-Processing Systems Market Size 2024	USD 5,056.76 million
U.S. Single-Use Bio-Processing Systems Market, CGR	16.33%
U.S. Single-Use Bio-Processing Systems Market Size 2032	USD 16,958.85 million

Market Overview

U.S. Single-Use Bio-Processing Systems market size was valued at USD 5,056.76 million in 2024 and is anticipated to reach USD 16,958.85 million by 2032, at a CAGR of 16.33% during the forecast period (2024-2032).

The U.S. Single-Use Bio-Processing Systems market is driven by the increasing demand for flexible, cost-effective, and scalable solutions in biopharmaceutical manufacturing. These systems offer advantages such as reduced contamination risks, faster setup times, and lower operational costs compared to traditional multi-use systems. Additionally, the growing trend of personalized medicine and biologics, along with the rising need for efficient vaccine production, is accelerating market growth. The shift towards biologics and monoclonal antibodies, coupled with advancements in cell culture technologies, further supports the adoption of single-use systems. Furthermore, regulatory bodies’ encouragement of flexible manufacturing approaches and the need for environmentally sustainable production processes are key factors contributing to market expansion. As biopharmaceutical companies focus on increasing production capacity while maintaining high-quality standards, the demand for single-use systems continues to rise, positioning them as essential tools in modern bio-manufacturing processes.

The U.S. Single-Use Bio-Processing Systems market is characterized by significant geographical variation, with key regions including the Western, Midwestern, Southern, and Northeastern United States. The Western U.S., driven by strong biotechnology hubs like California, leads the market, followed by the Midwestern region, home to many pharmaceutical manufacturing facilities. The Southern U.S. is emerging as a major player due to its lower operational costs and expanding bio-manufacturing sector. The Northeastern U.S., known for its focus on research and development, also contributes to the market’s growth. Key players in this market include Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, and Meissner Filtration Products, Inc. These companies lead innovation in single-use bio-processing systems, offering advanced products like bioreactors, mixers, and connectors. Their strategic focus on research, expansion of product portfolios, and partnerships with biotech firms further solidify their positions in the growing U.S. bio-processing industry.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The U.S. Single-Use Bio-Processing Systems market was valued at USD 5,056.76 million in 2024 and is projected to reach USD 16,958.85 million by 2032, growing at a CAGR of 16.33% during the forecast period.
The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.
The increasing demand for biologics and personalized medicine is driving the adoption of flexible and scalable production solutions like single-use systems.
Market trends show a shift towards modular and fully disposable systems, integrating automation and digitalization to improve production efficiency.
Key competitors include Thermo Fisher Scientific, Danaher Corporation, and Pall Corporation, all of which lead through innovation and strategic partnerships.
High initial costs of disposable components and environmental concerns about waste management are major market restraints.
The Western U.S. leads the market, followed by the Midwest, South, and Northeast, with each region showing growth based on local manufacturing needs.
Regulatory support and increasing demand for biologics contribute to expanding market opportunities, particularly in the R&D and manufacturing sectors.

Report Scope

This report segments the U.S. Single-Use Bio-Processing Systems Market as follows:

Market Drivers

Cost-Effectiveness and Operational Efficiency

One of the key drivers of the U.S. Single-Use Bio-Processing Systems market is the significant reduction in operational costs they offer compared to traditional stainless-steel systems. Single-use systems eliminate the need for costly cleaning, sterilization, and maintenance procedures that are inherent in multi-use equipment. For instance, American Pharmaceutical Review highlights that single-use bioprocessing systems improve efficiency by reducing labor costs and minimizing downtime between batches. This not only reduces labor costs but also shortens turnaround times between batches, increasing overall operational efficiency. The lower capital investment and reduced time to market make these systems particularly attractive for both large and small-scale biopharmaceutical companies. Furthermore, single-use systems’ flexibility allows companies to adapt more easily to fluctuating production demands without committing to expensive, permanent infrastructure.

Increasing Demand for Biologics and Personalized Medicine

The rising demand for biologics, including monoclonal antibodies, gene therapies, and vaccines, is a significant driver for the adoption of single-use bio-processing systems. As the global biopharmaceutical industry shifts towards biologic-based treatments, manufacturers require scalable, adaptable solutions to meet evolving production needs. Single-use systems offer enhanced flexibility in scaling up or down production based on demand without the need for expensive facility modifications. Additionally, the trend towards personalized medicine, which involves tailoring treatments to individual patients, further accelerates the need for more agile and customized manufacturing processes. These systems support efficient, smaller-batch productions that are necessary for personalized therapeutic applications, thus driving the market forward.

Sustainability and Environmental Concerns

Sustainability is becoming an increasingly important factor in manufacturing, with environmental concerns prompting industries to adopt greener practices. Single-use bio-processing systems contribute to reducing environmental impact by minimizing water and energy consumption, as well as the need for harsh cleaning chemicals. For instance, Cytiva’s Life Cycle Assessment studies indicate that single-use systems reduce CO2 emissions and water consumption compared to traditional stainless-steel bioprocessing. Since these systems are disposed of after use, they eliminate the need for water-intensive cleaning cycles required by traditional multi-use systems. Additionally, the adoption of recyclable and biodegradable materials in single-use components is further enhancing their sustainability profile. As companies face growing pressure from stakeholders, including investors and regulators, to adopt more eco-friendly practices, single-use systems present an attractive solution that aligns with both environmental goals and operational efficiency.

Regulatory Support and Standardization

Regulatory bodies in the U.S. have shown increasing support for single-use technologies due to their contribution to reducing contamination risks and improving production efficiency. The U.S. Food and Drug Administration (FDA) and other regulatory agencies have acknowledged the advantages of single-use systems in promoting safety, quality, and compliance in biopharmaceutical manufacturing. The push for more sustainable and flexible manufacturing processes aligns with global regulatory trends encouraging innovation in bio-processing technologies. Standardization of single-use components, along with improved guidelines for their use, has further facilitated market growth, ensuring that manufacturers can rely on consistent and proven systems to meet stringent quality control and regulatory requirements.

Market Trends

Shift Toward Disposable and Modular Systems

One of the most notable trends in the U.S. Single-Use Bio-Processing Systems market is the shift toward modular and fully disposable systems. Manufacturers are increasingly adopting modular designs, which allow for easy customization and faster deployment in bio-manufacturing processes. These modular systems can be quickly integrated into existing production lines, offering greater flexibility in managing production scale and reducing downtime. The rise of fully disposable components such as bags, filters, and tubing reduces the risk of cross-contamination between batches, streamlining production and improving overall process integrity. This trend is being driven by the demand for faster, more adaptable solutions to meet growing market needs.

Advances in Material Science and Product Innovation

Material science advancements are significantly impacting the evolution of single-use bio-processing systems. The development of new materials that offer enhanced performance, durability, and compatibility with various biologics is fueling the growth of this market. For instance, the Asian Journal of Hospital Pharmacy has reported that innovations in single-use materials are improving contamination control and regulatory compliance. Manufacturers are now able to produce single-use components that better withstand extreme processing conditions while maintaining product sterility and integrity. Innovations in biocompatible materials, such as those resistant to oxidation and degradation, are helping to enhance the reliability and scalability of these systems. As the market for biologics continues to expand, manufacturers are focused on improving the functionality of single-use products to meet the needs of more complex and sensitive bio-manufacturing applications.

Expansion in Cell and Gene Therapy Manufacturing

The U.S. Single-Use Bio-Processing Systems market is also being influenced by the rapid growth of cell and gene therapies, which require specialized manufacturing solutions. These therapies often involve complex and smaller-scale production, which is ideal for single-use systems that offer flexibility and adaptability. For instance, NovaOne Advisor reports that the U.S. single-use bioprocessing market is expanding due to the increasing demand for cell and gene therapy manufacturing. The customization capabilities of single-use systems allow for precise control over the manufacturing process, which is crucial for maintaining the integrity and effectiveness of these advanced therapies. As the demand for cell and gene therapies continues to rise, single-use bio-processing systems are becoming integral to the development and commercialization of these next-generation treatments. This trend is expected to drive further innovation in the single-use systems market, with an increasing focus on tailored solutions for these emerging therapeutic areas.

Integration of Automation and Digitalization

Another emerging trend in the single-use bio-processing market is the integration of automation and digital technologies. As biopharmaceutical manufacturing becomes more complex, there is a growing emphasis on optimizing production processes through automation. Automated systems can monitor and control critical process parameters such as temperature, pH, and oxygen levels, ensuring consistent product quality and increasing operational efficiency. Digital tools like real-time data analytics and process monitoring systems enable manufacturers to make data-driven decisions, improve process control, and predict potential issues before they occur. The combination of single-use technologies with automation and digitalization is transforming bio-manufacturing into a more precise and efficient operation.

Market Challenges Analysis

Concerns Over Cost of Single-Use Components

Despite the numerous advantages of single-use bio-processing systems, the high cost of disposable components remains a significant challenge for many manufacturers. While single-use systems can reduce overall operational costs by eliminating cleaning and maintenance, the upfront expenses for consumables such as bags, filters, and tubing can be substantial. For large-scale manufacturers, these recurring costs can accumulate, particularly when dealing with high-volume production. Small and mid-sized biopharmaceutical companies may find it difficult to justify the investment in single-use systems if the cost per unit becomes too high. Manufacturers must balance the benefits of reduced facility infrastructure and labor costs with the expense of continually purchasing new components, making cost management a key challenge for widespread adoption.

Issues with Waste Disposal and Sustainability

While single-use systems offer significant operational benefits, the disposal of used components poses environmental challenges. The large volume of plastic and other materials generated from single-use products creates a considerable waste management concern. For instance, BioPharm International reports that while single-use systems reduce water and energy consumption, disposal remains a critical issue due to bio-hazardous waste classification. Though some single-use products are made from recyclable materials, the lack of a fully sustainable recycling infrastructure in the biopharmaceutical industry complicates efforts to reduce the environmental footprint. Additionally, the limited ability to reuse these components means that they contribute to growing landfill waste, raising questions about the long-term environmental impact of single-use systems. Manufacturers face increasing pressure to adopt greener alternatives, but the industry is still in the process of finding comprehensive solutions to address waste disposal, sustainability, and the reduction of resource consumption. As environmental regulations become more stringent, addressing these concerns will be critical for the continued growth and acceptance of single-use bio-processing systems.

Market Opportunities

The U.S. Single-Use Bio-Processing Systems market presents several significant growth opportunities, particularly as the demand for biologics and advanced therapies continues to rise. One of the primary opportunities lies in the expansion of personalized medicine and gene therapies, which require flexible, scalable, and cost-effective manufacturing solutions. Single-use systems are ideally suited for the production of small to medium-sized batches, making them essential for the development and commercialization of personalized treatments. As more biopharmaceutical companies shift towards biologics, including monoclonal antibodies, cell therapies, and vaccines, the adoption of single-use systems is expected to accelerate. This trend offers manufacturers the opportunity to capitalize on the growing need for faster, more efficient, and adaptive production methods that align with the complexities of biologic drug development.

Additionally, advancements in material science and the integration of automation and digital technologies open new avenues for market growth. Manufacturers are increasingly seeking ways to enhance the performance and reliability of single-use components, which offers significant potential for innovation. The development of new materials that provide greater durability, resistance to contamination, and compatibility with advanced biologics presents opportunities for creating higher-quality systems. Furthermore, the integration of automation and digitalization into bio-manufacturing processes improves overall efficiency and precision, enabling manufacturers to meet stringent production requirements while reducing the risk of human error. As the industry increasingly embraces Industry 4.0 technologies, there is a clear opportunity for single-use system providers to expand their product offerings and incorporate advanced features that improve process control and data management, further boosting market growth.

Market Segmentation Analysis:

By Type:

The U.S. Single-Use Bio-Processing Systems market is segmented by product type, with key components including single-use bioreactors, single-use mixers, single-use bags, single-use connectors, and others. Among these, single-use bioreactors hold the largest market share due to their critical role in cell culture and fermentation processes, which are integral to the production of biologics. These bioreactors offer scalability, flexibility, and cost-efficiency, making them essential in the production of monoclonal antibodies, vaccines, and other biologic drugs. Single-use mixers are also experiencing significant growth, as they support efficient mixing of cell cultures and media in bioprocessing. Single-use bags are widely used for fluid storage, transport, and mixing in bio-manufacturing, with increasing demand for bag systems that can handle large volumes. Single-use connectors play a vital role in the safe transfer of fluids between systems, ensuring aseptic conditions and reducing contamination risks. As the market continues to evolve, the demand for these components is expected to grow, driven by their ability to reduce contamination, increase flexibility, and lower capital expenditures in biopharmaceutical production.

By Application:

The application segment of the U.S. Single-Use Bio-Processing Systems market is driven by several critical sectors, including research and development, manufacturing, process development, commercial production, and others. Research and development is a growing segment as biopharmaceutical companies seek efficient solutions for early-stage drug development, particularly in gene and cell therapies. The manufacturing segment is also significant, driven by the ongoing shift towards biologic drugs, with single-use systems providing manufacturers with flexible and scalable production capabilities. In process development, these systems offer a valuable tool for optimizing bio-manufacturing workflows, ensuring that production processes are more efficient and adaptable. The commercial production segment is experiencing robust growth as single-use systems enable cost-effective large-scale production of biologics, without the need for expensive, permanent infrastructure. As biopharmaceutical companies continue to expand their production capabilities, these segments offer substantial opportunities for growth. The increasing adoption of single-use systems in diverse applications positions the market for continued expansion across various stages of bio-manufacturing.

Segments:

Based on Type:

Single-Use Bioreactors
Single-Use Mixers
Single-Use Bags
Single-Use Connectors
Others

Based on Application:

Research & Development
Manufacturing
Process Development
Commercial Production
Others

Based on End- User:

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Contract Manufacturing Organizations (CMOs)
Others

Based on the Geography:

Western United States
Midwestern United States
Southern United States
Northeastern United States

Regional Analysis

Western United States

The Western United States holds the largest market share, accounting for approximately 35% of the total market. This dominance can be attributed to the presence of numerous biopharmaceutical companies and leading research institutions, particularly in California and Washington. The region is home to a strong biotechnology ecosystem, with a focus on innovative biologics and gene therapies, which require advanced manufacturing solutions such as single-use systems. Additionally, the Western U.S. has seen significant investment in bio-manufacturing facilities, driving demand for flexible and cost-efficient production methods. The favorable regulatory environment and a high concentration of industry leaders further bolster the region’s substantial market share.

Midwestern United States

The Midwestern United States holds a significant share, contributing around 25% to the U.S. Single-Use Bio-Processing Systems market. States like Illinois, Wisconsin, and Ohio are key players in the region, with a strong presence of pharmaceutical manufacturers and contract research organizations (CROs). The Midwest’s established industrial base and its strategic position for logistics and supply chain management make it an attractive hub for bio-manufacturing. The region has seen increasing adoption of single-use systems as pharmaceutical companies look to enhance production efficiency and reduce costs. Additionally, the growing focus on biologics and vaccines in the Midwest contributes to the rising demand for flexible bio-processing solutions.

Southern United States

The Southern United States is another important market for single-use bio-processing systems, capturing approximately 20% of the market share. The region has experienced significant growth in recent years, with states like Texas, Georgia, and North Carolina emerging as key centers for bio-manufacturing. The South benefits from a combination of factors, including lower operational costs, favorable tax incentives, and a rapidly expanding biotechnology sector. As more pharmaceutical companies establish production facilities in the South, the demand for single-use bio-processing systems is expected to grow, especially in commercial production and manufacturing applications. The Southern U.S. is positioning itself as a key player in the national bio-manufacturing landscape.

Northeastern United States

The Northeastern United States holds the smallest market share, accounting for around 15% of the total U.S. market. However, this region is still a critical player, especially in terms of research and development. Major cities like Boston and New York are home to top-tier universities and biotech firms focused on cutting-edge therapeutic areas, such as gene and cell therapies. While the Northeastern U.S. has fewer large-scale manufacturing facilities compared to other regions, its significant role in R&D and process development contributes to the adoption of single-use bio-processing systems. The region’s concentration of innovation and its growing focus on biologics and advanced therapies are expected to drive future market growth, though at a slightly slower pace than the other regions.

Key Player Analysis

Thermo Fisher Scientific Inc.
Danaher Corporation
Corning Incorporated
Entegris, Inc.
Meissner Filtration Products, Inc.
Repligen Corporation
PBS Biotech, Inc.
Avantor, Inc.
Saint-Gobain Performance Plastics
Pall Corporation

Competitive Analysis

The U.S. Single-Use Bio-Processing Systems market is highly competitive, with key players such as Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Entegris, Inc., Meissner Filtration Products, Inc., Repligen Corporation, PBS Biotech, Inc., Avantor, Inc., Saint-Gobain Performance Plastics, and Pall Corporation leading the industry. These companies have established strong market positions through continuous innovation, product diversification, and strategic acquisitions. These players leverage strong research and development capabilities, which enable them to introduce cutting-edge solutions that enhance production efficiency, scalability, and flexibility. The competitive landscape is shaped by key strategies such as strategic partnerships, acquisitions, and the expansion of global distribution networks. As the market evolves, companies are increasingly incorporating automation and digital technologies into their bio-processing solutions, improving process control and data management. In addition, advancements in material science have led to the development of high-performance components that offer better durability, reduced contamination risks, and greater compatibility with complex biologics production. Market leaders are also addressing environmental concerns by focusing on sustainable solutions, such as recyclable materials for single-use components. Moreover, increasing investments in biologics, vaccines, and gene therapies have led to higher demand for specialized and flexible bio-processing systems, further intensifying competition. As companies strive to stay ahead in this growing market, their ability to innovate and adapt to emerging trends is crucial for maintaining a competitive edge.

Recent Developments

In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The U.S. Single-Use Bio-Processing Systems market exhibits moderate concentration, with a few dominant players holding significant market share. These companies are characterized by their extensive product portfolios, strong research and development capabilities, and global reach, enabling them to cater to the growing demand in the biopharmaceutical industry. The market is primarily driven by technological advancements, with key players investing heavily in innovation to offer scalable, flexible, and cost-effective solutions for biologics and personalized medicine production. As the industry expands, market characteristics include a high degree of product specialization, as companies focus on developing single-use systems for specific applications such as cell culture, filtration, and fluid management. Additionally, the increasing emphasis on sustainability and reducing environmental impact is shaping market dynamics, with players introducing more eco-friendly solutions. Despite the presence of several smaller players, the market remains competitive, with major companies leading through technological advancements and strategic collaborations.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The U.S. single-use bioprocessing market is projected to continue its robust growth trajectory, driven by increasing demand for biologics and personalized medicine.
Advancements in automation and digitalization are enhancing process efficiency and scalability, making single-use systems more attractive for large-scale production.
Integration of artificial intelligence and machine learning is enabling real-time monitoring and predictive analytics, improving product quality and reducing variability.
The expansion of personalized medicine, particularly in oncology and immunology, is fueling the need for flexible and adaptable manufacturing solutions.
Modular bioprocessing units are gaining traction, offering compact, scalable, and cost-effective solutions for biomanufacturing.
Sustainability concerns are prompting the development of eco-friendly single-use components and recyclable materials to minimize environmental impact.
Strategic collaborations and partnerships are facilitating innovation and expanding market reach, particularly in emerging therapeutic areas.
Regulatory bodies are increasingly focusing on establishing standardized guidelines for single-use systems to ensure quality and safety in biomanufacturing.
Supply chain resilience is becoming a priority, with efforts to diversify sources and mitigate risks associated with raw material shortages.
The U.S. is expected to maintain its leadership in the global single-use bioprocessing market, supported by strong infrastructure and investment in biomanufacturing capabilities.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. U.S. Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by U.S. 31

5.1.1. U.S. Single-Use Bio-Processing Systems Market Import Volume/Revenue, By U.S., 2018 – 2023 31

5.2. Export Analysis by U.S. 32

5.2.1. U.S. Single-Use Bio-Processing Systems Market Export Volume/Revenue, By U.S., 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by U.S. 33

6.1.1. U.S. Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By U.S., 2018 – 2023 33

6.2. Supply Analysis by U.S. 34

6.2.1. U.S. Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By U.S., 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by U.S. 35

7.1.1. U.S. Single-Use Bio-Processing Systems Market Production Volume/Revenue, By U.S., 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. U.S. Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. U.S. Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. U.S. Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. U.S. Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. U.S. Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. U.S. Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. U.S. Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. U.S. Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

U.S. Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – U.S. ANALYSIS 76

16.1. Type 76

16.1.1. U.S. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. U.S. Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. U.S. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. U.S. Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. U.S. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. U.S. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

CHAPTER NO. 17 : COMPANY PROFILES 79

17.1. Thermo Fisher Scientific Inc. 79

17.1.1. Company Overview 79

17.1.2. Product Portfolio 79

17.1.3. Swot Analysis 79

17.1.4. Business Strategy 80

17.1.5. Financial Overview 80

17.2. Danaher Corporation 81

17.3. Corning Incorporated 81

17.4. Entegris, Inc. 81

17.5. Meissner Filtration Products, Inc. 81

17.6. Repligen Corporation 81

17.7. PBS Biotech, Inc. 81

17.8. Avantor, Inc. 81

17.9. Saint-Gobain Performance Plastics 81

17.10. Pall Corporation 81

List of Figures

FIG NO. 1. U.S. Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for U.S. Single-Use Bio-Processing Systems Market 29

FIG NO. 3. U.S. Single-Use Bio-Processing Systems Market Import Volume/Revenue, By U.S., 2018 – 2023 31

FIG NO. 4. U.S. Single-Use Bio-Processing Systems Market Export Volume/Revenue, By U.S., 2018 – 2023 32

FIG NO. 5. U.S. Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By U.S., 2018 – 2023 33

FIG NO. 6. U.S. Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By U.S., 2018 – 2023 34

FIG NO. 7. U.S. Single-Use Bio-Processing Systems Market Production Volume/Revenue, By U.S., 2018 – 2023 35

FIG NO. 8. U.S. Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for U.S. Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. U.S. Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. U.S. Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. U.S. Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. U.S. Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. U.S. Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. U.S. Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. U.S. Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. U.S. Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. U.S. Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. U.S. Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. U.S. Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. U.S. Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. U.S. Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. U.S. Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. U.S. Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : U.S. Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : U.S. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : U.S. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : U.S. Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : U.S. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : U.S. Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : U.S. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : U.S. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

Frequently Asked Questions

What is the current size of the U.S. Single-Use Bio-Processing Systems market?

The market was valued at USD 5,056.76 million in 2024 and is expected to reach USD 16,958.85 million by 2032.

What factors are driving the growth of the U.S. Single-Use Bio-Processing Systems market?

Key drivers include rising demand for biologics, cost efficiency, regulatory support, and the push for personalized medicine.

What are the key segments within the U.S. Single-Use Bio-Processing Systems market?

The market is segmented by Type (e.g., bioreactors, bags), Application (e.g., manufacturing, R&D), and End-User (e.g., CMOs, biotech firms).

Who are the major players in the U.S. Single-Use Bio-Processing Systems market?

Leading companies include Thermo Fisher Scientific, Danaher Corporation, Pall Corporation, Corning Inc., and Meissner Filtration Products.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –